Atasu K. Nayak, MD
See Publications

Texas Heart Institute Positions

  • Teaching Staff, Cardiovascular Disease Fellowship
  • Teaching Staff, Interventional Cardiology Fellowship

Interests

  • Cardiology
  • Interventional Cardiology
  • Echocardiography

Education

  • Medical School:

    Shri Ramachandra Bhanj Medical College, India

  • Internship:

    Lincoln Medical, Mental Health Center, New York Medical College

  • Residency:

    New York Medical College

  • Fellowships:

    University of Missouri (Columbia, MO) — Cardiology
    Lahey Clinic (Burlington, MA) — Interventional Cardiology

Academic & Clinical Affiliations

Honors, Awards and Memberships

  • The Texas Heart Institute Academic Professional Staff
  • Texas Super Doctors, Texas Monthly Magazine
  • Member, The Texas Heart Institute Cardiac Society
  • Fellow, Society of Vascular Medicine
  • Fellow, American College of Cardiology
  • Fellow, American College of Physicians and American Society of Internal Medicine,
  • Fellow, Society of Cardiac Angiography and Interventions
  • Life Member, GOSUMEC Alumni Association, Seth GS Medical College, Bombay, India.
  • Fellow, Society of Cardiac Angiography and Intervention since 2004
  • Fellow, Society of Vascular Medicine and Biology
  • Member, Harris County Medical Society and Texas Medical Association
  • Board member, Houston Indian Doctors Associatio
  • Medical Council of India. M.C.I.
  • Member, AAPI (American Association of Physicians of Indian Origin) since 2005
  • Member, Houston IDA (Indian Doctors Association) since 2006
  • Chief Cardiology Fellow, New York Medical College

Publications

4862227 QSTRXYIF 1 alternatives-to-animal-experimentation 10 date desc Nayak 2026 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22XU5K87AP%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kanda%20et%20al.%22%2C%22parsedDate%22%3A%222014%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKanda%2C%20B.%20S.%2C%20%26lt%3Bstrong%26gt%3BNayak%26lt%3B%5C%2Fstrong%26gt%3B%2C%20A.%20K.%2C%20Posligua%2C%20W.%20et%20al.%20%282014%29.%20Recurrent%20broken%20heart%20syndrome%3A%20Case%20report%20and%20review.%20%26lt%3Bi%26gt%3BThe%20New%20York%20Medical%20Journal%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B8%26lt%3B%5C%2Fi%26gt%3B%2C%208%26%23x2013%3B13.%20Available%20at%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fnewyorkmedicaljournal.org%5C%2Farticles%5C%2Frecurrent-broken-heart-syndrome-2%5C%2F%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fnewyorkmedicaljournal.org%5C%2Farticles%5C%2Frecurrent-broken-heart-syndrome-2%5C%2F%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Recurrent%20broken%20heart%20syndrome%3A%20Case%20report%20and%20review%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Binder%20S.%22%2C%22lastName%22%3A%22Kanda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Atasu%20K.%22%2C%22lastName%22%3A%22Nayak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%22%2C%22lastName%22%3A%22Posligua%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Paniagua%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Waleed%20T.%22%2C%22lastName%22%3A%22Kayani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mahboob%22%2C%22lastName%22%3A%22Alam%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2212-2014%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%282154-9400%29%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fnewyorkmedicaljournal.org%5C%2Farticles%5C%2Frecurrent-broken-heart-syndrome-2%5C%2F%22%2C%22collections%22%3A%5B%22ZL4RPFGU%22%2C%22MGN9A7SF%22%2C%22QSTRXYIF%22%5D%2C%22dateModified%22%3A%222019-11-18T14%3A51%3A49Z%22%7D%7D%2C%7B%22key%22%3A%22VSP4J5EG%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Birtcher%20et%20al.%22%2C%22parsedDate%22%3A%222010-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBirtcher%2C%20K.%20K.%2C%20Greisinger%2C%20A.%20J.%2C%20Brehm%2C%20B.%20J.%20et%20al.%20%282010%29.%20A%20secondary%20prevention%20lipid%20clinic%20reaches%20low-density%20lipoprotein%20cholesterol%20goals%20more%20often%20than%20usual%20cardiology%20care%20with%20coronary%20heart%20disease.%20%26lt%3Bi%26gt%3BJ%20Clin%20Lipidol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B4%26lt%3B%5C%2Fi%26gt%3B%2C%2046%26%23x2013%3B52.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jacl.2009.12.001%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jacl.2009.12.001%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20secondary%20prevention%20lipid%20clinic%20reaches%20low-density%20lipoprotein%20cholesterol%20goals%20more%20often%20than%20usual%20cardiology%20care%20with%20coronary%20heart%20disease%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kim%20K.%22%2C%22lastName%22%3A%22Birtcher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anthony%20J.%22%2C%22lastName%22%3A%22Greisinger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%20J.%22%2C%22lastName%22%3A%22Brehm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oscar%20A.%22%2C%22lastName%22%3A%22Wehmanen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Loriann%20M.%22%2C%22lastName%22%3A%22Furman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cathryn%20C.%22%2C%22lastName%22%3A%22Salinas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Madjid%22%2C%22lastName%22%3A%22Mirzai-Tehrane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Atasu%22%2C%22lastName%22%3A%22Nayak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haroonur%22%2C%22lastName%22%3A%22Rashid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%22%2C%22lastName%22%3A%22Mortazavi%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20The%20objective%20of%20this%20study%20was%20to%20determine%20whether%20enrollment%20in%20a%20multidisciplinary%20secondary%20prevention%20lipid%20clinic%20%28SPLC%29%20for%203%20or%20more%20years%20was%20associated%20with%20improved%20adherence%20to%20lipid%20guidelines%20as%20compared%20with%20usual%20care%20provided%20by%20cardiologists.%5CnMETHODS%3A%20Patients%20with%20documented%20coronary%20artery%20disease%20%28CAD%29%2C%20enrolled%20in%20a%20SPLC%2C%20and%20followed%20for%20at%20least%203%20years%20were%20identified%20by%20the%20use%20of%20a%20computer%20database.%20The%20comparison%20group%20included%20patients%20with%20CAD%20who%20received%20usual%20care%20from%20a%20cardiologist%20during%20the%20same%20time%20period.%20The%20percentage%20of%20patients%20achieving%20low-density%20lipoprotein%20cholesterol%20%28LDL-C%29%20goals%20at%20enrollment%20and%20after%20at%20least%203%20years%20of%20follow-up%20was%20determined%20for%20both%20groups.%20The%20average%20total%20cholesterol%2C%20LDL-C%2C%20high-density%20lipoprotein%20cholesterol%20%28HDL-C%29%2C%20and%20triglycerides%20were%20determined%20after%20at%20least%203%20years%20of%20follow-up%20for%20both%20groups.%5CnRESULTS%3A%20Patients%20enrolled%20in%20the%20SPLC%20reached%20the%20LDL-C%20goals%20more%20often%20than%20usual%20care%20cardiology%20patients%20%28goal%20%26lt%3B100mg%5C%2FdL%3A%2081.9%25%20vs.%2072.8%25%2C%20P%20%26lt%3B%20.001%3B%20optional%20goal%20%26lt%3B70%20mg%5C%2FdL%3A%2041.9%25%20vs.%2028.6%25%2C%20P%20%26lt%3B%20.001%29.%20The%20patients%20enrolled%20in%20the%20SPLC%20had%20lower%20average%20total%20cholesterol%2C%20triglycerides%2C%20and%20LDL-C%20and%20greater%20average%20HDL-C%20after%203%20years.%20All%20the%20lipid%20parameters%20decreased%20for%20patients%20in%20usual%20cardiology%20care%2C%20but%20these%20changes%20were%20not%20statistically%20significant.%5CnCONCLUSIONS%3A%20This%20multidisciplinary%20secondary%20prevention%20lipid%20clinic%20achieved%20the%20LDL-C%20goals%20%28%26lt%3B100mg%5C%2FdL%20and%20optional%20goal%20%26lt%3B70%20mg%5C%2FdL%29%20more%20often%20than%20usual%20cardiology%20care%20for%20patients%20with%20CAD%20after%203%20years%20of%20lipid%20management.%22%2C%22date%22%3A%222010%20Jan-Feb%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jacl.2009.12.001%22%2C%22ISSN%22%3A%221933-2874%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22Z2XX7DHR%22%2C%22RU3NKKRV%22%2C%22QSTRXYIF%22%2C%223PSVM3AY%22%5D%2C%22dateModified%22%3A%222018-05-02T20%3A20%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22CQWGK8XW%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Nayak%20et%20al.%22%2C%22parsedDate%22%3A%222006-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BNayak%26lt%3B%5C%2Fstrong%26gt%3B%2C%20A.%20K.%2C%20Kawamura%2C%20A.%2C%20Nesto%2C%20R.%20W.%20et%20al.%20%282006%29.%20Myocardial%20infarction%20as%20a%20presentation%20of%20clinical%20in-stent%20restenosis.%20%26lt%3Bi%26gt%3BCirc%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B70%26lt%3B%5C%2Fi%26gt%3B%2C%201026%26%23x2013%3B1029.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1253%5C%2Fcircj.70.1026%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1253%5C%2Fcircj.70.1026%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Myocardial%20infarction%20as%20a%20presentation%20of%20clinical%20in-stent%20restenosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Atasu%20K.%22%2C%22lastName%22%3A%22Nayak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akio%22%2C%22lastName%22%3A%22Kawamura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20W.%22%2C%22lastName%22%3A%22Nesto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gershan%22%2C%22lastName%22%3A%22Davis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Jarbeau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20T.%22%2C%22lastName%22%3A%22Pyne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20E.%22%2C%22lastName%22%3A%22Gossman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20C.%22%2C%22lastName%22%3A%22Piemonte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nabila%22%2C%22lastName%22%3A%22Riskalla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manish%20S.%22%2C%22lastName%22%3A%22Chauhan%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20In-stent%20restenosis%20is%20considered%20to%20be%20a%20gradual%20and%20progressive%20condition%20and%20there%20is%20scant%20data%20on%20myocardial%20infarction%20%28MI%29%20as%20a%20clinical%20presentation.%5CnMETHODS%20AND%20RESULTS%3A%20Of%202%2C462%20consecutive%20patients%20who%20underwent%20percutaneous%20coronary%20intervention%20between%20June%202001%20and%20December%202002%2C%20clinical%20in-stent%20restenosis%20occurred%20in%20212%20%288.6%25%29%2C%20who%20were%20classified%20into%203%20groups%3A%20ST%20elevation%20MI%20%28STEMI%29%2C%20non-ST%20elevation%20MI%20%28NSTEMI%29%20and%20non-MI.%20Of%20the%20212%20patients%20presenting%20with%20clinical%20in-stent%20restenosis%2C%2022%20%2810.4%25%29%20had%20MI%20%28creatine%20kinase%20%28CK%29%26gt%3Bor%3D2xbaseline%20with%20elevated%20CKMB%29.%20The%20remaining%20190%20%2889.6%25%29%20patients%20had%20stable%20angina%20or%20evidence%20of%20ischemia%20by%20stress%20test%20without%20elevation%20of%20cardiac%20enzymes.%20Median%20interval%20between%20previous%20intervention%20and%20presentation%20for%20clinical%20in-stent%20restenosis%20was%20shorter%20for%20patients%20with%20MI%20than%20for%20non-MI%20patients%20%28STEMI%2C%2090%20days%3B%20NSTEMI%2C%2079%20days%3B%20non-MI%2C%20125%20days%3B%20p%3D0.07%29.%20Diffuse%20in-stent%20restenosis%20was%20more%20frequent%20in%20MI%20patients%20than%20in%20non-MI%20patients%20%2872.7%25%20vs%2056.3%25%3B%20p%26lt%3B0.005%29.%20Renal%20failure%20was%20more%20prevalent%20in%20patients%20with%20MI%20than%20in%20those%20without%20MI%20%2831.8%25%20vs%206.3%25%2C%20p%3D0.001%29.%20Compared%20with%20the%20non-MI%20group%2C%20patients%20with%20MI%20were%20more%20likely%20to%20have%20acute%20coronary%20syndromes%20at%20the%20time%20of%20index%20procedure%20%2881.8%25%20vs%2056.8%25%2C%20p%3D0.02%29.%5CnCONCLUSION%3A%20Clinical%20in-stent%20restenosis%20can%20frequently%20present%20as%20MI%20and%20such%20patients%20are%20more%20likely%20to%20have%20an%20aggressive%20angiographic%20pattern%20of%20restenosis.%20Renal%20failure%20and%20acute%20coronary%20syndromes%20at%20the%20initial%20procedure%20are%20associated%20with%20MI.%22%2C%22date%22%3A%222006-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1253%5C%2Fcircj.70.1026%22%2C%22ISSN%22%3A%221346-9843%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22QSTRXYIF%22%5D%2C%22dateModified%22%3A%222022-02-10T16%3A50%3A40Z%22%7D%7D%2C%7B%22key%22%3A%2266LG4SY2%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Iskander%20et%20al.%22%2C%22parsedDate%22%3A%222005-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BIskander%2C%20A.%2C%20%26lt%3Bstrong%26gt%3BNayak%26lt%3B%5C%2Fstrong%26gt%3B%2C%20A.%20and%20Chauhan%2C%20M.%20S.%20%282005%29.%20Submassive%20pulmonary%20embolism%20and%20paradoxical%20embolic%20stroke%20treated%20with%20percutaneous%20rheolytic%20thrombectomy%20and%20closure%20of%20the%20patent%20foramen%20ovale.%20%26lt%3Bi%26gt%3BCatheter%20Cardiovasc%20Interv%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B64%26lt%3B%5C%2Fi%26gt%3B%2C%20356%26%23x2013%3B360.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fccd.20306%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fccd.20306%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Submassive%20pulmonary%20embolism%20and%20paradoxical%20embolic%20stroke%20treated%20with%20percutaneous%20rheolytic%20thrombectomy%20and%20closure%20of%20the%20patent%20foramen%20ovale%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ayman%22%2C%22lastName%22%3A%22Iskander%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Atasu%22%2C%22lastName%22%3A%22Nayak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manish%20S.%22%2C%22lastName%22%3A%22Chauhan%22%7D%5D%2C%22abstractNote%22%3A%22The%20presence%20of%20patent%20foramen%20ovale%20%28PFO%29%20in%20patients%20with%20large%20pulmonary%20emboli%20%28PE%29%20is%20associated%20with%20an%20increased%20risk%20of%20stroke%20and%20mortality.%20Many%20patients%20are%20ineligible%20to%20receive%20thrombolytic%20therapy.%20We%20present%20a%20patient%20with%20bilateral%20PE%20and%20cryptogenic%20stroke%20who%20was%20treated%20effectively%20with%20rheolytic%20thrombectomy%20with%20AngioJet%2C%20PFO%20closure%20with%20CardioSeal%20device%2C%20and%20placement%20of%20an%20inferior%20vena%20cava%20filter.%22%2C%22date%22%3A%222005-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fccd.20306%22%2C%22ISSN%22%3A%221522-1946%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22QSTRXYIF%22%5D%2C%22dateModified%22%3A%222022-02-10T16%3A50%3A40Z%22%7D%7D%2C%7B%22key%22%3A%22LBRA2I43%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Aggarwal%20et%20al.%22%2C%22parsedDate%22%3A%222002-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAggarwal%2C%20K.%2C%20Jayam%2C%20V.%20K.%2C%20Meyer%2C%20M.%20A.%20et%20al.%20%282002%29.%20Thrombus-in-transit%20and%20paradoxical%20embolism.%20%26lt%3Bi%26gt%3BJ%20Am%20Soc%20Echocardiogr%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B15%26lt%3B%5C%2Fi%26gt%3B%2C%201021%26%23x2013%3B1022.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1067%5C%2Fmje.2002.121279%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1067%5C%2Fmje.2002.121279%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Thrombus-in-transit%20and%20paradoxical%20embolism%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kul%22%2C%22lastName%22%3A%22Aggarwal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vinod%20K.%22%2C%22lastName%22%3A%22Jayam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20A.%22%2C%22lastName%22%3A%22Meyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Atasu%20K.%22%2C%22lastName%22%3A%22Nayak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sriram%22%2C%22lastName%22%3A%22Nathan%22%7D%5D%2C%22abstractNote%22%3A%22Paradoxical%20embolism%20is%20an%20uncommon%20but%20clinically%20important%20phenomenon.%20Elements%20of%20diagnosis%20include%20the%20presence%20of%3A%20%281%29%20a%20venous%20thrombus%2C%20%282%29%20an%20arterial%20embolus%2C%20%283%29%20a%20communication%20between%20the%20right%20and%20left%20heart%2C%20and%20%284%29%20a%20thrombus%20traversing%20such%20a%20communication.%20Unfortunately%2C%20all%20of%20these%20elements%20can%20be%20rarely%20demonstrated%20in%20each%20case%20but%20the%20probability%20should%20be%20considered%20in%20any%20patient%20with%202%20or%20more%20present.%20It%20should%20be%20suspected%20in%20patients%20who%20have%20evidence%20of%20systemic%20arterial%20emboli%20without%20apparent%20cause.%20A%20transesophageal%20echocardiogram%20with%20contrast%20should%20be%20considered%20in%20cases%20where%20paradoxical%20embolism%20is%20a%20possibility.%20We%20present%20a%20case%20in%20which%20a%20%26quot%3Bthrombus-in-transit%26quot%3B%20was%20imaged%20across%20the%20interatrial%20septum%20in%20a%20patient%20with%20a%20patent%20foramen%20ovale%2C%20deep%20venous%20thrombosis%2C%20and%20an%20embolic%20cerebrovascular%20stroke.%22%2C%22date%22%3A%222002-09%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1067%5C%2Fmje.2002.121279%22%2C%22ISSN%22%3A%220894-7317%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22QSTRXYIF%22%5D%2C%22dateModified%22%3A%222022-02-10T16%3A50%3A40Z%22%7D%7D%2C%7B%22key%22%3A%22C2KWTGZZ%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Nayak%20and%20Komatireddy%22%2C%22parsedDate%22%3A%222002-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BNayak%26lt%3B%5C%2Fstrong%26gt%3B%2C%20A.%20K.%20and%20Komatireddy%2C%20G.%20%282002%29.%20Cardiac%20manifestations%20of%20the%20antiphospholipid%20antibody%20syndrome%3A%20a%20review.%20%26lt%3Bi%26gt%3BMo%20Med%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B99%26lt%3B%5C%2Fi%26gt%3B%2C%20171%26%23x2013%3B178%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cardiac%20manifestations%20of%20the%20antiphospholipid%20antibody%20syndrome%3A%20a%20review%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Atasu%20K.%22%2C%22lastName%22%3A%22Nayak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geetha%22%2C%22lastName%22%3A%22Komatireddy%22%7D%5D%2C%22abstractNote%22%3A%22The%20antiphospholipid%20antibody%20syndrome%20%28APLAS%29%2C%20though%20an%20uncommon%20entity%20involves%20multiple%20organs%20in%20the%20body.%20The%20antiphospholipid%20antibodies%20%28APLA%29%20refer%20to%20several%20groups%20of%20autoantibodies%20against%20negatively%20charged%20phospholipids%20occurring%20independently%20or%20in%20association%20with%20systemic%20lupus%20erythematosus%20%28SLE%29%20and%20related%20autoimmune%20disorders.%20Several%20studies%20to%20date%20found%20those%20patients%20with%20APLA%2C%20predominantly%20IgG%20and%20to%20lesser%20extent%20IgM%20isotype%20and%20lupus%20anticoagulant%20%28LAC%29%20are%20associated%20with%20arterial%20and%20venous%20thrombosis%2C%20recurrent%20fetal%20loss%2C%20thrombocytopenia%2C%20and%20livedo%20reticularis.%20We%20have%20described%20two%20cases%20of%20APLAS%2C%20one%20primary%20and%20the%20other%20secondary%2C%20their%20management%20and%20cardiac%20manifestations.%20Cardiac%20manifestations%20of%20the%20syndrome%20include%20coronary%20artery%20thrombosis%20and%20valvular%20heart%20disease.%20These%20can%20be%20serious%20and%20difficult%20to%20treat.%20Although%20the%20exact%20treatment%20of%20the%20cardiac%20manifestations%20of%20APLAS%20is%20not%20clear%2C%20anticoagulation%20is%20the%20currently%20recommended%20therapy.%22%2C%22date%22%3A%222002-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%220026-6620%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22QSTRXYIF%22%5D%2C%22dateModified%22%3A%222022-02-10T16%3A50%3A40Z%22%7D%7D%5D%7D
Kanda, B. S., Nayak, A. K., Posligua, W. et al. (2014). Recurrent broken heart syndrome: Case report and review. The New York Medical Journal 8, 8–13. Available at: https://newyorkmedicaljournal.org/articles/recurrent-broken-heart-syndrome-2/.
Birtcher, K. K., Greisinger, A. J., Brehm, B. J. et al. (2010). A secondary prevention lipid clinic reaches low-density lipoprotein cholesterol goals more often than usual cardiology care with coronary heart disease. J Clin Lipidol 4, 46–52. https://doi.org/10.1016/j.jacl.2009.12.001.
Nayak, A. K., Kawamura, A., Nesto, R. W. et al. (2006). Myocardial infarction as a presentation of clinical in-stent restenosis. Circ J 70, 1026–1029. https://doi.org/10.1253/circj.70.1026.
Iskander, A., Nayak, A. and Chauhan, M. S. (2005). Submassive pulmonary embolism and paradoxical embolic stroke treated with percutaneous rheolytic thrombectomy and closure of the patent foramen ovale. Catheter Cardiovasc Interv 64, 356–360. https://doi.org/10.1002/ccd.20306.
Aggarwal, K., Jayam, V. K., Meyer, M. A. et al. (2002). Thrombus-in-transit and paradoxical embolism. J Am Soc Echocardiogr 15, 1021–1022. https://doi.org/10.1067/mje.2002.121279.
Nayak, A. K. and Komatireddy, G. (2002). Cardiac manifestations of the antiphospholipid antibody syndrome: a review. Mo Med 99, 171–178